Aggregation of equine platelets by PAF (platelet-activating factor).

Area of Science:

• Biochemistry
• Immunology
• Veterinary Medicine

Background:

• Platelet-activating factor (PAF) is a potent lipid mediator involved in allergic reactions.
• PAF is known to be a strong platelet agonist and hypotensive agent.
• Understanding PAF's role in equine platelet function is crucial for veterinary research.

Purpose of the Study:

• To investigate the effects of PAF on equine platelet aggregation.
• To determine the sensitivity of equine platelets to PAF.
• To explore the involvement of the arachidonate pathway in PAF-induced equine platelet aggregation.

Main Methods:

• Equine platelet-rich plasma (PRP) and washed platelets were stimulated with varying concentrations of PAF.
• Platelet aggregation was measured over time.
• The effect of exogenous arachidonate and aspirin pretreatment on PAF-induced aggregation was assessed.

Main Results:

• Equine platelets aggregated in a time- and dose-dependent manner in response to PAF.
• Significant aggregation occurred at PAF concentrations as low as 3.58 x 10(-14) M (PRP) and 3.58 x 10(-16) M (washed platelets).
• PAF-induced aggregation was not breed-dependent and did not involve the arachidonate pathway, as evidenced by lack of enhancement with arachidonate and no inhibition by aspirin.

Conclusions:

• Equine platelets are highly sensitive to PAF, aggregating at very low concentrations.
• The arachidonate pathway is not implicated in PAF-induced platelet aggregation in horses.
• These findings contribute to understanding allergic and inflammatory responses in horses.